Background & Purpose

Sweden needs a reliable way to manufacture critical medicines during peacetime crises, heightened states of alert, and wartime. To achieve this, the state-owned company APL needs financial support to acquire a specific manufacturing business.

The Decision

The Swedish parliament approved the government's proposal for an extra amending budget, allowing a capital injection of up to 700 million SEK to APL during 2025.

Does this affect you?

  • State-owned enterprises: APL receives a substantial capital injection of up to 700 million SEK to carry out strategic acquisitions.
  • Healthcare sector: Access to critical medicines is secured through improved domestic manufacturing preparedness during crises.

In Practice

  • The state provides up to 700 million SEK in financial support to the state-owned company APL.
  • APL can now proceed to quickly acquire the new manufacturing business.
  • Sweden strengthens its preparedness and manufacturing capacity for critical medicines.